SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vincent Chow, Caroline Reddel, Gabrielle Pennings, Elizabeth Scott, Tundra Pasqualon, Austin C.C. Ng, Thomas Yeoh, Jennifer Curnow, Leonard Kritharides, Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy, Schizophrenia Research, 2015, 162, 1-3, 175

    CrossRef

  2. 2
    Corrado Barbui, Valentino Conti, Andrea Cipriani, Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies, Drug Safety, 2014, 37, 2, 79

    CrossRef

  3. 3
    Gianluca Trifiró, Janet Sultana, Edoardo Spina, Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies, Drug Safety, 2014, 37, 7, 501

    CrossRef

  4. 4
    Jeffrey K. Aronson, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2014,

    CrossRef

  5. 5
    Niklas Schmedt, Edeltraut Garbe, Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia, Journal of Clinical Psychopharmacology, 2013, 33, 6, 753

    CrossRef

  6. 6
    Chi-Shin Wu, Chia-Ming Chang, Chuan-Yu Chen, Erin Chia-Hsuan Wu, Kuan-Yi Wu, Hsin-Yi Liang, Yu-Lin Chao, Wen-Shen Isabella Chung, Hui-Ju Tsai, Association Between Antidepressants and Venous Thromboembolism in Taiwan, Journal of Clinical Psychopharmacology, 2013, 33, 1, 31

    CrossRef

  7. 7
    Patients receiving antipsychotic agents have an increased risk of venous thromboembolism, Drugs & Therapy Perspectives, 2013, 29, 1, 20

    CrossRef

  8. 8
    Maria Skokou, Philippos Gourzis, Pulmonary Embolism Related to Amisulpride Treatment: A Case Report, Case Reports in Psychiatry, 2013, 2013, 1

    CrossRef

  9. 9
    Xinsheng Liu, Fintan O'Rourke, Huong Van Nguyen, Venous thromboembolism in psychogeriatric in-patients – A study of risk assessment, incidence, and current prophylaxis prescribing, International Psychogeriatrics, 2013, 25, 06, 913

    CrossRef

  10. 10
    Cécile Tromeur, Francis Couturaud, Antipsychotic drugs and venous thromboembolism, Thrombosis Research, 2012, 130, S29

    CrossRef

  11. 11
    Massimo Gallerani, Davide Imberti, Elisa Mari, Anna Marra, Roberto Manfredini, Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature, Acta Neuropsychiatrica, 2012, 24, 6
  12. 12
    Anna K. Jönsson, Olav Spigset, Staffan Hägg, Venous Thromboembolism in Recipients of Antipsychotics, CNS Drugs, 2012, 26, 8, 649

    CrossRef

  13. 13
    Hannah H. Larsen, James C. Ritchie, Marcia D. McNutt, Dominique L. Musselman, Pulmonary Embolism in a Patient with Catatonia: An Old Disease, Changing Times, Psychosomatics, 2011, 52, 4, 387

    CrossRef

  14. 14
    Bart C. Kleijer, Eibert R. Heerdink, Toine C.G. Egberts, Paul A.F. Jansen, Rob J. van Marum, Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients, Journal of Clinical Psychopharmacology, 2010, 30, 5, 526

    CrossRef

  15. 15
    Anne-Marie Rousseau, Hyperprolactinemia and Atypical Antipsychotic Therapy in a Case of Fatal Thromboembolism, Journal of Clinical Psychopharmacology, 2010, 30, 6, 734

    CrossRef

  16. 16
    Susan S. Jick, Lin Li, Antidepressant Drug Use and Risk of Venous Thromboembolism, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008, 28, 2
  17. 17
    Anna K. Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson, Staffan Hägg, Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series, International Clinical Psychopharmacology, 2008, 23, 5, 263

    CrossRef

  18. 18
    Staffan Hägg, Andrew Bate, Malin Stahl, Olav Spigset, Associations Between Venous Thromboembolism and Antipsychotics, Drug Safety, 2008, 31, 8, 685

    CrossRef

  19. 19
    Edgardo Carrizo, Virginia Fernández, Jesús Quintero, Lissette Connell, Zulay Rodríguez, Mônica Mosquera, Arnaldo Acosta, Trino Baptista, Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives, Schizophrenia Research, 2008, 103, 1-3, 83

    CrossRef

  20. 20
    Felicia A. Smith, Curtis W. Wittmann, Theodore A. Stern, Medical Complications of Psychiatric Treatment, Critical Care Clinics, 2008, 24, 4, 635

    CrossRef

  21. 21
    K. Lacut, D. Mottier, P. Pottier, Médicaments et maladie veineuse thromboembolique, Revue de Pneumologie Clinique, 2008, 64, 6, 290

    CrossRef

  22. 22
    K. Lacut, G. Le Gal, F. Couturaud, G. Cornily, C. Leroyer, D. Mottier, E. Oger, Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case–control study, Fundamental & Clinical Pharmacology, 2007, 21, 6
  23. 23
    Stina Axelsson, Staffan Hägg, Andreas C Eriksson, Tomas L Lindahl, Per A Whiss, IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION, Clinical and Experimental Pharmacology and Physiology, 2007, 34, 8
  24. 24
    S. B. Laursen, T. N. Jensen, T. Bolwig, N. V. Olsen, Deep venous thrombosis and pulmonary embolism following physical restraint, Acta Psychiatrica Scandinavica, 2005, 111, 4
  25. 25
    Sirpa Hartikainen, Terhi Rahkonen, Hannu Kautiainen, Raimo Sulkava, The use of psychotropics and survival in demented elderly individuals, International Clinical Psychopharmacology, 2005, 20, 4, 227

    CrossRef

  26. 26
    Trino Baptista, Soaira De Mendoza, Serge Beaulieu, Andrés Bermúdez, Maritza Martinez, The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management, Metabolic Syndrome and Related Disorders, 2004, 2, 4, 290

    CrossRef

  27. 27
    Aslı Kurne, Aygun Ertugrul, A. Elif Anıl Yağcıoğlu, Kazım M. Yazıcı, Venous thromboembolism and escitalopram, General Hospital Psychiatry, 2004, 26, 6, 481

    CrossRef